Tabea Bartsch

Dresden, SN 01328, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Cell-free protein synthesis with technical additives - expanding the parameter space of in vitro gene expression.

Cell-free protein synthesis with technical additives - expanding the parameter space of in vitro gene expression.

Journal: Beilstein journal of organic chemistry
Published: June 13, 2024

UniCAR T-Cell Potency-A Matter of Affinity between Adaptor Molecules and Adaptor CAR T-Cells?

UniCAR T-Cell Potency-A Matter of Affinity between Adaptor Molecules and Adaptor CAR T-Cells?

Journal: International journal of molecular sciences
Published: May 31, 2024

Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells.

Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells.

Journal: Frontiers in immunology
Published: September 26, 2023

A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells.

A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells.

Journal: Frontiers in immunology
Published: April 12, 2023

Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma.

Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma.

Journal: Cancers
Published: February 07, 2022

Nanosensors in clinical development of CAR-T cell immunotherapy.

Nanosensors in clinical development of CAR-T cell immunotherapy.

Journal: Biosensors & bioelectronics
Published: October 29, 2021

A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity.

A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity.

Journal: International journal of molecular sciences
Published: September 23, 2021

Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy.

Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy.

Journal: Cancers
Published: August 20, 2021

And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling.

And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling.

Journal: International journal of molecular sciences
Published: July 19, 2021

Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner.

Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner.

Journal: International journal of molecular sciences
Published: February 14, 2021

Biotechnological production of cyclic dinucleotides-Challenges and opportunities.

Biotechnological production of cyclic dinucleotides-Challenges and opportunities.

Journal: Biotechnology and bioengineering
Published: January 11, 2021

T Cell Mediated Conversion of a Non-Anti-La Reactive B Cell to an Autoreactive Anti-La B Cell by Somatic Hypermutation.

T Cell Mediated Conversion of a Non-Anti-La Reactive B Cell to an Autoreactive Anti-La B Cell by Somatic Hypermutation.

Journal: International journal of molecular sciences
Published: December 29, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026